- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 243/10 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 243/10
Total number of patents in this class: 83
10-year publication summary
2
|
4
|
4
|
5
|
4
|
10
|
1
|
6
|
3
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Nippon Chemiphar Co., Ltd. | 228 |
14 |
Boehringer Ingelheim International GmbH | 4704 |
4 |
Kyushu University, National University Corporation | 1643 |
4 |
Otsuka Pharmaceutical Co., Ltd. | 1502 |
4 |
Neuropore Therapies, Inc. | 38 |
3 |
TONIX Pharmaceuticals Holding Corp | 32 |
3 |
Tonix Pharmaceuticals, Inc. | 41 |
3 |
Merck Sharp & Dohme LLC | 3741 |
3 |
Novartis AG | 10904 |
2 |
Bristol-myers Squibb Company | 4892 |
2 |
Boehringer Ingelheim Pharma GmbH & Co. Kg | 592 |
2 |
Purdue Research Foundation | 3564 |
2 |
Dana-Farber Cancer Institute, Inc. | 2553 |
2 |
Gilead Sciences, Inc. | 2028 |
2 |
ImmunoGen, Inc. | 399 |
2 |
Merck & Co., Inc. | 371 |
1 |
Bayer Pharma AG | 1061 |
1 |
The Regents of the University of Michigan | 4670 |
1 |
Takeda Pharmaceutical Company Limited | 2704 |
1 |
Alkermes Pharma Ireland Limited | 271 |
1 |
Other owners | 26 |